Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
New BHF Chief Technology Officer Appointed
British Heart Foundation are delighted to have appointed Alex Duncan as their new Chief Technology Officer (CTO). Alex, who is […]
New Clot Busting Drug Could Improve Stroke Treatment
A new clot busting drug developed by scientists at the University of Manchester is able […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]
New Technique Makes Heart Transplant Possible for More Children in Need
A new technique developed by researchers BHF funded at Great Ormond Street Hospital for Children […]
BHF Research Could Help Detect Early Signs of Heart Failure in Diabetic Patients
New research that BHF have funded in Leicester could help understand how heart failure can […]
AI Breakthrough for Faster, Cheaper and Injection-free Heart Scans
New artificial intelligence (AI) technology could lead to the next generation of heart MRI scans […]
New Research to Study Benefits of Personalised Pacemaker Programming
Researchers BHF have funded at the University of Leeds will investigate how people living with […]
Genes Responsible for High Blood Pressure Discovered in the Human Kidney
Research that the British Heart Foundation part-funded has led to the discovery of 179 kidney […]
Glowing Probe Could Diagnose Cardiovascular Disease Earlier
Researchers have created a probe that glows when it detects an enzyme associated with issues […]
- Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
- Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
- BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
- Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
- GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more